Abbott Laboratories
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 35.7B 40.1B 43.7B 43.1B
Cost of revenue 15.9B 18.0B 19.1B 18.5B
Gross profit 19.8B 22.1B 24.5B 24.5B
Operating expense
Research & development 2.4B 2.7B 2.9B 2.7B
Selling general and admin 10.0B 10.9B 11.2B 11.3B
Other operating expenses
Operating income 5.8B 6.5B 8.4B 8.4B
Non operating interest income
Income 293.0M 385M 183M 43M
Expense 476.1M 637M 558M 533M
Other income expense 343.3M 438M 319M 276M
Pretax income 6.0B 6.7B 8.3B 8.2B
Tax provision -5.4B 941M 1.4B 1.1B
Net income 11.4B 5.7B 6.9B 7.1B
Basic EPS 7.7 3.3 4.0 4.0
Diluted EPS 7.6 3.3 3.9 3.9
Basic average shares 1.5B 1.8B 1.8B 1.8B
Diluted average shares 1.5B 1.8B 1.8B 1.8B
EBITDA 9.2B 10.6B 12.1B 12.3B
Net income from continuing op. 11.4B 5.7B 6.9B 7.1B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 1 hour 40 minutes

06:19
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).